pulmonary arterial hypertension: Pulmonary arterial hypertension (PAH) is a group of diseases characterized by elevated pulmonary arterial resistance leading to right heart failure. PAH is progressive and potentially fatal. PAH may be idiopathic and/ or familial, or induced by drug or toxin (drug-or toxin-induced PAH, see these terms) or associated with other diseases like congenital heart disease, connective tissue disease, HIV, schistosomiasis, portal hypertension (PAH associated with other disease, see this term).
Filter registries Inpat., Oupat., Death
Check pre-conditions None
Check conditions None
Apply sex-specific rule None
I9_PULMOTHHD
Extra metadata
List of similar endpoints to
Other pulmonary heart/vessel disease
based on the number of shared cases.
Broader endpoints:
Narrower endpoints:
| All | Female | Male | |
|---|---|---|---|
| Number of individuals | 650 | 324 | 326 |
| Unadjusted prevalence (%) | 0.25 | 0.22 | 0.29 |
| Mean age at first event (years) | 62.58 | 60.53 | 64.62 |
| Follow-up | Absolute risk | HR [95% CI] | p | N |
|---|---|---|---|---|
| 1998–2019 | - | - | - | - |
| 15 years | - | - | - | - |
| 5 years | - | - | - | - |
| 1 year | - | - | - | - |
Index endpoint: I9_PULMOTHHD – Other pulmonary heart/vessel disease
GWS hits: 0
before Other pulmonary heart/vessel disease
after Other pulmonary heart/vessel disease
Loading survival analyses plot
Loading survival analyses table